FDA.reportPublic FDA data

tofacitinib

RxCUI
1357536
RxNorm name
tofacitinib
Term type
IN
Status
Active
Updated
2026-07-23 06:55:39

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122012
Active start
122012
Multiple ingredient
NO
Branded
NO

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRtofacitinib1NAMES
RxNorm Nametofacitinib1NAMES
TTYIN1ATTRIBUTES
SPL_SET_ID
27 linked values
27CODES
UNII_CODE87LA6FU8301CODES
RxCUI13575361CODES
MMSL_CODE
2 linked values
2CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 22 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TOFACITINIBTOFACITINIBExelan pharmaceuticals,Ince68680e5-0328-4e66-b8bb-4af126221ec72026-05-01Boxed warning, Warnings, Adverse reactionsName fallback
generic name: TOFACITINIB
Tofacitinib XRTOFACITINIBBiocon Pharma Incf0160e3d-63ea-75fb-4b88-fe3d6a6ce0302026-04-09Boxed warning, Warnings, Adverse reactionsName fallback
generic name: TOFACITINIB

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL04AFJanus-associated kinase (JAK) inhibitorsATC1-4tofacitinib
FDASPLN0000190858Janus Kinase InhibitorEPChas_epctofacitinib
FDASPLN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib
MEDRTD010880PiperidinesCHEMhas_ingredienttofacitinib
MEDRTD010880PiperidinesCHEMhas_ingredienttofacitinib citrate
MEDRTD011743PyrimidinesCHEMhas_ingredienttofacitinib
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treattofacitinib
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treattofacitinib citrate
MEDRTN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib
MEDRTN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib citrate
MEDRTN0000008656Decreased HematopoiesisPEhas_petofacitinib
MEDRTN0000008656Decreased HematopoiesisPEhas_petofacitinib citrate
MEDRTN0000175550Decreased Immunologic ActivityPEhas_petofacitinib
MEDRTN0000175550Decreased Immunologic ActivityPEhas_petofacitinib citrate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESATCL04AF01
CODESDRUGBANKDB08895
CODESSNOMEDCT704313003
CODESSNOMEDCT704316006
CODESVUID4031786
SOURCESSourceAnatomical Therapeutic Chemical
SOURCESSourceDrug Bank
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File